EG20542A - Process for preparing of benzopyrons compounds - Google Patents
Process for preparing of benzopyrons compoundsInfo
- Publication number
- EG20542A EG20542A EG13694A EG13694A EG20542A EG 20542 A EG20542 A EG 20542A EG 13694 A EG13694 A EG 13694A EG 13694 A EG13694 A EG 13694A EG 20542 A EG20542 A EG 20542A
- Authority
- EG
- Egypt
- Prior art keywords
- pct
- compounds
- formula
- image
- dashed line
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 abstract 1
- 230000004899 motility Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Plural Heterocyclic Compounds (AREA)
- Glass Compositions (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Pyrane Compounds (AREA)
- Dental Preparations (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939304917A GB9304917D0 (en) | 1993-03-10 | 1993-03-10 | Benzopyrans |
| GB939308368A GB9308368D0 (en) | 1993-03-10 | 1993-04-22 | Benzopyrans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG20542A true EG20542A (en) | 1999-07-31 |
Family
ID=26302564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG13694A EG20542A (en) | 1993-03-10 | 1994-03-07 | Process for preparing of benzopyrons compounds |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5677324A (sv) |
| EP (1) | EP0690855B1 (sv) |
| JP (1) | JP3137649B2 (sv) |
| CN (1) | CN1119014A (sv) |
| AT (1) | ATE146468T1 (sv) |
| AU (1) | AU674940B2 (sv) |
| BR (1) | BR9406818A (sv) |
| CA (1) | CA2155837C (sv) |
| CZ (1) | CZ230895A3 (sv) |
| DE (1) | DE69401201T2 (sv) |
| DK (1) | DK0690855T3 (sv) |
| EG (1) | EG20542A (sv) |
| ES (1) | ES2097041T3 (sv) |
| FI (1) | FI115055B (sv) |
| GR (1) | GR3022517T3 (sv) |
| HU (1) | HUT73784A (sv) |
| IL (1) | IL108841A0 (sv) |
| MY (1) | MY110494A (sv) |
| NO (1) | NO953573D0 (sv) |
| NZ (1) | NZ262897A (sv) |
| PL (1) | PL310553A1 (sv) |
| SG (1) | SG42910A1 (sv) |
| WO (1) | WO1994020491A1 (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4841700A (en) | 1999-05-12 | 2000-11-21 | Nitromed, Inc. | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use |
| AU2001286557A1 (en) * | 2000-08-23 | 2002-03-04 | Merck Frosst Canada And Co. | Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists |
| RU2006129320A (ru) * | 2004-02-12 | 2008-02-27 | Уорнер-Ламберт Компани Ллс (Us) | Способ стимулирования роста волос |
| CN104487427B (zh) * | 2012-06-25 | 2017-03-15 | 萨尼奥纳有限责任公司 | 四唑衍生物和它们作为钾通道调节剂的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1479518A (en) * | 1973-12-27 | 1977-07-13 | Erba Carlo Spa | 5,6-benzo-ypsilon-pyrone derivatives |
| DE3811017A1 (de) * | 1988-03-31 | 1989-10-19 | Hoechst Ag | Ungesaettigte n-benzopyranyllactame |
| EP0346724A1 (de) * | 1988-06-16 | 1989-12-20 | MERCK PATENT GmbH | Chromanderivate |
-
1994
- 1994-03-03 IL IL10884194A patent/IL108841A0/xx not_active IP Right Cessation
- 1994-03-04 EP EP94910364A patent/EP0690855B1/en not_active Expired - Lifetime
- 1994-03-04 NZ NZ262897A patent/NZ262897A/en unknown
- 1994-03-04 CN CN94191420A patent/CN1119014A/zh active Pending
- 1994-03-04 DK DK94910364.2T patent/DK0690855T3/da active
- 1994-03-04 MY MYPI94000520A patent/MY110494A/en unknown
- 1994-03-04 WO PCT/EP1994/000637 patent/WO1994020491A1/en active IP Right Grant
- 1994-03-04 CZ CZ952308A patent/CZ230895A3/cs unknown
- 1994-03-04 PL PL94310553A patent/PL310553A1/xx unknown
- 1994-03-04 HU HU9501918A patent/HUT73784A/hu unknown
- 1994-03-04 AT AT94910364T patent/ATE146468T1/de not_active IP Right Cessation
- 1994-03-04 AU AU62826/94A patent/AU674940B2/en not_active Ceased
- 1994-03-04 CA CA002155837A patent/CA2155837C/en not_active Expired - Fee Related
- 1994-03-04 ES ES94910364T patent/ES2097041T3/es not_active Expired - Lifetime
- 1994-03-04 US US08/501,080 patent/US5677324A/en not_active Expired - Fee Related
- 1994-03-04 SG SG1996000633A patent/SG42910A1/en unknown
- 1994-03-04 DE DE69401201T patent/DE69401201T2/de not_active Expired - Fee Related
- 1994-03-04 BR BR9406818A patent/BR9406818A/pt not_active Application Discontinuation
- 1994-03-04 JP JP06519578A patent/JP3137649B2/ja not_active Expired - Fee Related
- 1994-03-07 EG EG13694A patent/EG20542A/xx active
-
1995
- 1995-09-08 FI FI954218A patent/FI115055B/sv not_active IP Right Cessation
- 1995-09-11 NO NO953573A patent/NO953573D0/no unknown
-
1997
- 1997-02-12 GR GR960403348T patent/GR3022517T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2155837A1 (en) | 1994-09-15 |
| AU6282694A (en) | 1994-09-26 |
| US5677324A (en) | 1997-10-14 |
| NZ262897A (en) | 1997-06-24 |
| NO953573L (no) | 1995-09-11 |
| JPH08503225A (ja) | 1996-04-09 |
| WO1994020491A1 (en) | 1994-09-15 |
| SG42910A1 (en) | 1997-10-17 |
| DE69401201T2 (de) | 1997-04-17 |
| ATE146468T1 (de) | 1997-01-15 |
| FI115055B (sv) | 2005-02-28 |
| CZ230895A3 (en) | 1995-12-13 |
| HUT73784A (en) | 1996-09-30 |
| BR9406818A (pt) | 1996-09-10 |
| ES2097041T3 (es) | 1997-03-16 |
| PL310553A1 (en) | 1995-12-27 |
| MY110494A (en) | 1998-06-30 |
| CA2155837C (en) | 1999-07-27 |
| DE69401201D1 (de) | 1997-01-30 |
| HU9501918D0 (en) | 1995-09-28 |
| NO953573D0 (no) | 1995-09-11 |
| FI954218A (sv) | 1995-09-08 |
| GR3022517T3 (en) | 1997-05-31 |
| IL108841A0 (en) | 1994-06-24 |
| CN1119014A (zh) | 1996-03-20 |
| DK0690855T3 (da) | 1997-06-02 |
| EP0690855B1 (en) | 1996-12-18 |
| EP0690855A1 (en) | 1996-01-10 |
| JP3137649B2 (ja) | 2001-02-26 |
| AU674940B2 (en) | 1997-01-16 |
| FI954218A0 (sv) | 1995-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69327541D1 (en) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
| AU6073596A (en) | Intermediates useful in the preparation of 5-HT4 receptor antagonists | |
| PT638075E (pt) | Inibidor da reaccao de maillard | |
| EG20542A (en) | Process for preparing of benzopyrons compounds | |
| PH31388A (en) | N-benzoylmethyl-piperidines. | |
| IL110845A0 (en) | Pyridazinone derivatives or their salts, processes or their production and anti-shock agents containing them | |
| NO933241L (no) | Aminosyrer nyttige ved terapi av osteoartikulaere paavirkninger | |
| PL312582A1 (en) | Use of cephem derivatives as antimetastatic means | |
| GB9022858D0 (en) | Derivatives of indoles | |
| AU4713697A (en) | Process for the preparation of N-(2-(dimethylamino)ethyl)acridine-4-carboxamide | |
| ATE173259T1 (de) | Verfahren zur herstellung von indolizinderivaten | |
| SI0817786T1 (en) | Substituted tetronic acids useful for treating hiv and other retroviruses | |
| ATE112281T1 (de) | Verfahren zur herstellung von streptograminderivaten. | |
| AU7351787A (en) | 2,2,6,6-diethylene-3-oxo-17-alpha-pregn-4-en-21,17- carbolactones | |
| IL117083A0 (en) | Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical agents containing these compounds |